Войти в систему Зарегистрироваться бесплатно

Apellis Pharmaceuticals Inc Доход Y / Y

Что обозначает Доход Y / Y в Apellis Pharmaceuticals Inc?

Доход Y / Y Apellis Pharmaceuticals Inc является 240.74%

Какое определение для Доход Y / Y?

Ежегодный рост выручки за последние 3 года является ростом выручки одного года к следующему, усреднённый за последние 3 года.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Доход Y / Y компаний в Health Care сектор на NASDAQ по сравнению с Apellis Pharmaceuticals Inc

Что делает Apellis Pharmaceuticals Inc?

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

Компании с доход y / y похож на Apellis Pharmaceuticals Inc